Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
VERU

Price
2.69
Stock movement up
+0.10 (3.86%)
Company name
Veru Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
43.18M
Ent value
38.88M
Price/Sales
-
Price/Book
2.36
Div yield
10408.92%
Div growth
-
Growth years
2
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-64.73%
1 year return (CAGR)
-99.75%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share280.00
Dividend yield10408.92%
Payout frequencyQuarterly
Maximum yield13084.11%
Average yield3216.45%
Minimum yield21.88%
Discount to avg yield69.10%
Upside potential223.61%
Yield as % of max yield79.55%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield10408.92%
Current yield distribution16.15%
Yield at 100% (Min)21.88%
Yield at 90%37.78%
Yield at 80%42.88%
Yield at 50% (Median)53.69%
Yield at 20%8308.61%
Yield at 10%11456.90%
Yield at 0% (Max)13084.11%

Dividend per share

Loading...
Dividend per share data
Years of growth2 years
CCC status-
Dividend per share280.00
Payout frequencyQuarterly
Ex-div date28 Apr 2014
EPS (TTM)-1.55
EPS (1y forward)-1.42
EPS growth (5y)-64.73%
EPS growth (5y forward)-

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
VERUS&P500
DGR MR16.67%-13.74%
DGR TTM12.00%6.60%
DGR 3 years-7.31%
DGR 5 years-4.69%
DGR 10 years-6.30%
DGR 15 years-8.16%
Time since last change announced4696 days
EPS growth (5y)-64.73%
EPS growth (5y forward)-

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM--
Average--
Forward-19718.31%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.36
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count16.05M
EPS (TTM)-1.55
FCF per share (TTM)-2.05

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-123.53K
Operating income (TTM)-33.38M
Net income (TTM)-22.73M
EPS (TTM)-1.55
EPS (1y forward)-1.42

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash15.79M
Net receivables0.00
Total current assets18.92M
Goodwill6.88M
Intangible assets0.00
Property, plant and equipment3.71M
Total assets29.84M
Accounts payable3.12M
Short/Current long term debt2.36M
Total current liabilities7.79M
Total liabilities11.50M
Shareholder's equity18.33M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-30.04M
Capital expenditures (TTM)1.08K
Free cash flow (TTM)-30.04M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-123.97%
Return on Assets-76.17%
Return on Invested Capital-119.04%
Cash Return on Invested Capital-157.37%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.63
Daily high2.84
Daily low2.61
Daily Volume174K
All-time high23780.00
1y analyst estimate21.00
Beta-1.42
EPS (TTM)-1.55
Dividend per share280.00
Ex-div date28 Apr 2014
Next earnings date-

Downside potential

Loading...
Downside potential data
VERUS&P500
Current price drop from All-time high-99.99%-0.89%
Highest price drop-99.99%-19.00%
Date of highest drop31 Dec 20258 Apr 2025
Avg drop from high-98.30%-2.49%
Avg time to new high-6 days
Max time to new high322 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
VERU (Veru Inc) company logo
Marketcap
43.18M
Marketcap category
Small-cap
Description
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Employees
20
Investor relations
-
SEC filings
CEO
Mitchell Shuster Steiner
Country
USA
City
Miami
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...